224 related articles for article (PubMed ID: 26404114)
1. In situ biomarker discovery and label-free molecular histopathological diagnosis of lung cancer by ambient mass spectrometry imaging.
Li T; He J; Mao X; Bi Y; Luo Z; Guo C; Tang F; Xu X; Wang X; Wang M; Chen J; Abliz Z
Sci Rep; 2015 Sep; 5():14089. PubMed ID: 26404114
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathological Diagnosis of Thyroid Tumors Using Spatially Resolved Metabolomics.
Huang L; Mao X; Sun C; Li T; Song X; Li J; Gao S; Zhang R; Chen J; He J; Abliz Z
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209182
[TBL] [Abstract][Full Text] [Related]
3.
Wang Z; He B; Liu Y; Huo M; Fu W; Yang C; Wei J; Abliz Z
Acta Pharm Sin B; 2020 Jun; 10(6):1083-1093. PubMed ID: 32642414
[TBL] [Abstract][Full Text] [Related]
4. In Situ Metabolomics in Cancer by Mass Spectrometry Imaging.
Buck A; Aichler M; Huber K; Walch A
Adv Cancer Res; 2017; 134():117-132. PubMed ID: 28110648
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
6. De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry.
Prade VM; Kunzke T; Feuchtinger A; Rohm M; Luber B; Lordick F; Buck A; Walch A
Mol Metab; 2020 Jun; 36():100953. PubMed ID: 32278304
[TBL] [Abstract][Full Text] [Related]
7. Precision biomarker discovery powered by microscopy image fusion-assisted high spatial resolution ambient ionization mass spectrometry imaging.
Lin LE; Chen CL; Huang YC; Chung HH; Lin CW; Chen KC; Peng YJ; Ding ST; Wang MY; Shen TL; Hsu CC
Anal Chim Acta; 2020 Mar; 1100():75-87. PubMed ID: 31987155
[TBL] [Abstract][Full Text] [Related]
8. A graphical data processing pipeline for mass spectrometry imaging-based spatially resolved metabolomics on tumor heterogeneity.
Huang L; Mao X; Sun C; Luo Z; Song X; Li X; Zhang R; Lv Y; Chen J; He J; Abliz Z
Anal Chim Acta; 2019 Oct; 1077():183-190. PubMed ID: 31307708
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
10. 1,1'-binaphthyl-2,2'-diamine as a novel MALDI matrix to enhance the in situ imaging of metabolic heterogeneity in lung cancer.
Sun C; Liu W; Mu Y; Wang X
Talanta; 2020 Mar; 209():120557. PubMed ID: 31892065
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
Nagai K; Uranbileg B; Chen Z; Fujioka A; Yamazaki T; Matsumoto Y; Tsukamoto H; Ikeda H; Yatomi Y; Chiba H; Hui SP; Nakazawa T; Saito R; Koshiba S; Aoki J; Saigusa D; Tomioka Y
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1(Suppl 1):e8551. PubMed ID: 31412144
[TBL] [Abstract][Full Text] [Related]
12. Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
Neumann JM; Freitag H; Hartmann JS; Niehaus K; Galanis M; Griesshammer M; Kellner U; Bednarz H
J Cancer Res Clin Oncol; 2022 Feb; 148(2):351-360. PubMed ID: 34839410
[TBL] [Abstract][Full Text] [Related]
13. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics workflow for lung cancer: Discovery of biomarkers.
Tang Y; Li Z; Lazar L; Fang Z; Tang C; Zhao J
Clin Chim Acta; 2019 Aug; 495():436-445. PubMed ID: 31103622
[TBL] [Abstract][Full Text] [Related]
16. Spatially Resolved Metabolomics Based on Air-Flow-Assisted Desorption Electrospray Ionization-Mass Spectrometry Imaging Reveals Region-Specific Metabolic Alterations in Diabetic Encephalopathy.
Huo M; Wang Z; Fu W; Tian L; Li W; Zhou Z; Chen Y; Wei J; Abliz Z
J Proteome Res; 2021 Jul; 20(7):3567-3579. PubMed ID: 34137614
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive high-resolution mass spectrometry approach for characterization of metabolites by combination of ambient ionization, chromatography and imaging methods.
Berisha A; Dold S; Guenther S; Desbenoit N; Takats Z; Spengler B; Römpp A
Rapid Commun Mass Spectrom; 2014 Aug; 28(16):1779-91. PubMed ID: 25559448
[TBL] [Abstract][Full Text] [Related]
18. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
19. Spatially Resolved Metabolomics Method for Mapping the Global Molecular Landscape of Whole-Body Zebrafish (
Sun Y; Zhou Z; Xie B; Wang Z; Abliz Z
Anal Chem; 2023 Jun; 95(24):9164-9172. PubMed ID: 37264941
[TBL] [Abstract][Full Text] [Related]
20. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
